Status:
RECRUITING
Effect of Geriatric Intervention in Frail Patients with Gastric, Biliary, and Pancreatic Cancer Receiving Palliative Chemotherapy
Lead Sponsor:
Chang Gung Memorial Hospital
Conditions:
GI Cancer
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
Gastric, biliary and pancreatic cancer are commonly malignancies from gastro- intestinal tract in Taiwan. Because lack of specific symptoms at presentation and effective screening methodology, majorit...
Eligibility Criteria
Inclusion
- Patients aged sixty-five or older with metastatic or unresectable gastric, biliary, and pancreatic cancer.
- The patient must sign the informed consent form.
- Estimated survival period of more than 3 months.
- Conscious and able to communicate verbally or in writing, and willing to cooperate with invasive procedures.
Exclusion
- Patients with cognitive impairment or unable to cooperate with the interventional procedures as determined by the clinical physician.
- Patients receiving concurrent other anticancer treatments (radiation or surgery).
- Patients with multiple types of cancer requiring simultaneous treatment.
- Patients who have previously participated in this study during a prior chemotherapy regimen.
Key Trial Info
Start Date :
December 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2026
Estimated Enrollment :
138 Patients enrolled
Trial Details
Trial ID
NCT06040801
Start Date
December 1 2021
End Date
July 31 2026
Last Update
February 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chang Gung Memorial Hospital
Taoyuan District, Taiwan, Taiwan, 330